ASH 2020: Targeted therapies in r/r multiple myeloma

Bookmark and Share
Published: 8 Dec 2020
Views: 2678
Prof Marivi Mateos, Prof Meletios Dimopoulos, Prof Meral Beksaç, Dr Shaji Kumar

Prof Marivi Mateos (University of Salamanca, Spain) chairs an expert discussion with Prof Meletios Dimopoulos (University of Athens, Greec)Dr Shaji Kumar (Mayo Clinic, Rochester, USA) and Prof Meral Beksaç (Ankara University, Turkey) on the latest in targeted therapy for multiple myeloma from ASH 2020.

They discuss all the updates from this year’s ASH conference regarding targeted therapies for R/R multiple myeloma including the FORTE, APOLLO, IKEMA, ICARIA-MM and MAIA studies.

They also touch on the latest in newly diagnosed multiple myeloma and discuss the use of immunotherapy and CAR-T cells.

ecancer's filming has been kindly supported by Sanofi through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.